TEL P/E Ratio Analysis
Updated 5h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 22.4x means investors pay $22.40 for every $1 of the company’s annual earnings per share.
Sector Performance
48th percentileTEL
22.4x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
23.4x(Jul 2026)
Deep Analysis
The P/E ratio of 22.4x means investors pay $22.40 for every $1 of the company’s annual earnings per share.
That is just below the sector median of 23.2x, placing TEL at the 48th percentile among peers, so valuation is neither cheap nor expensive relative to its sector. The trend data is incomplete: the year-over-year change is N/A, but quarter-over-quarter the P/E fell by 4.0%, from 23.4x to 22.4x. A below-median valuation paired with a recent quarterly decline suggests reduced earnings multiple expansion or falling price relative to earnings, which can ease downside risk if fundamentals hold. However, with limited trend history and a neutral level, there is no strong mispricing signal. This metric supports the overall NEUTRAL verdict, as it shows fair valuation with no clear pressure to re-rate either direction.
Frequently Asked Questions
What does the P/E Ratio tell investors about TEL?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are TEL's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master TEL's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TEL research report →TEL
22.4x
Sector Median
23.1x
Sector Avg
33.7x
How TEL's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.